首页> 外文期刊>European review for medical and pharmacological sciences. >Remifentanil without muscle relaxants for intubation in microlaryngoscopy: A double blind randomised clinical trial
【24h】

Remifentanil without muscle relaxants for intubation in microlaryngoscopy: A double blind randomised clinical trial

机译:不用肌肉松弛药的瑞芬太尼在微喉镜检查中进行插管:一项双盲随机临床试验

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: We aimed to compare the effect of remifentanil without muscle relaxant with succinylcholine for intubation in microlaryngoscopy. PATIENTS AND METHODS: Eighty patients were randomly divided into two groups: Group R (n=40) and S (n=40) received remifentanil 4 μg/kg intravenously or 1 μg/kg respectively. Anesthesia was induced with 2 mg/kg propofol in both groups. Intubation was performed after bolus administration of 10 ml saline as a placebo or 1 mg/kg of succinylcholine in Group R and S respectively. Remifentanil infusion was initiated at 0.025 μg/kg in each groups. RESULTS: Intubation conditions were similar in both groups. The mean arterial pressure (MAP) values at post-induction period were significantly lower in the Group S than in the Group R (p = 0.001). The requirement for ephedrine in Group R was found to be significantly lower than Group S (p = 0.023). Recovery times were significantly shorter (p = 0.001) and recovery scores were significantly higher (p = 0.021) in Group R. Time to patient could respond to commands was significantly longer in the Group S (p = 0.001). The surgeon's satisfaction score was significantly higher in Group R (p = 0.001). CONCLUSIONS: It was concluded that remifentanil without muscle relaxants provides similar intubating conditions as that provided by succinylcholine, and remifentanil is superior to succinylcholine with regard to haemodynamic stability and recovery duration.
机译:目的:我们的目的是比较没有肌肉松弛剂的瑞芬太尼与琥珀酰胆碱在微喉镜中插管的效果。患者与方法:80例患者随机分为两组:R组(n = 40)和S(n = 40)分别接受瑞芬太尼4μg/ kg静脉滴注或1μg/ kg静脉滴注。两组均以2 mg / kg异丙酚诱导麻醉。在R组和S组分别推注10 ml生理盐水作为安慰剂或1 mg / kg琥珀酰胆碱后,进行插管。每组开始以0.025μg/ kg的剂量输注瑞芬太尼。结果:两组的插管条件相似。 S组诱导后平均动脉压(MAP)值显着低于R组(p = 0.001)。发现R组对麻黄碱的需求量明显低于S组(p = 0.023)。 R组的恢复时间显着缩短(p = 0.001),恢复分数显着更高(p = 0.021)。S组患者对命令做出响应的时间明显更长(p = 0.001)。 R组的外科医生满意度得分显着更高(p = 0.001)。结论:得出结论,没有肌肉松弛剂的瑞芬太尼可提供与琥珀胆碱相似的插管条件,并且瑞芬太尼在血液动力学稳定性和恢复时间方面优于琥珀胆碱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号